ASX Announcement U.S. Government Releases US$66.9 Billion Antimicrobial Resistance Biodefense Strategy Highlights: • United States Government outlines a five-year, US$66.9 billion strategy to strengthen national defences against pandemics and drug-resistant superbugs ...
U.S. Government Releases US$66.9B AMR Biodefense Strategy
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Vietnamese Patent Granted for RECCE Anti-Infectives
- AUD $3.7M Income Tax Refund Received
- Placement & SPP to raise $8 million
- HREC Approval Accelerates Global Phase 3 DFI Strategy
- Addendum to Recce Signs Middle East Licensing Term Sheet
Later from Recce Pharmaceuticals
- Notice of General Meeting/Proxy Form
- Application for quotation of securities - RCE
- Completion of Share Purchase Plan and Shortfall Notice
- Cleansing Notice
- Change of Director's Interest Notices (x4)
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals